drugset
drugset / Trial / NCT02947139

Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers

NCT02947139 ↗

Phase 1 Completed 53 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open label, crossover study to explore drug-drug interactions between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers

Timeline

Start
2016-09-29
Primary completion
2016-10-24
Completion
2016-11-02

Drugs

EvaluationDrugModalityDoseRoute
Subject DWC20155 Unknown — —
Subject DWC20156 Unknown — —
Subject DWC20161 Unknown — —

Indications

No indication recorded.